• Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
  • Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care.
  • We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company.
  • Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.

The success of Axis-Shield depends on its highly motivated and professional workforce. We spend a significant part of our turnover on research and development and employ a large number of scientists and graduates across many disciplines.

We have implemented and observed codes of conduct that are designed to protect employees from harassment or discrimination in any form, and to provide equality of opportunity

IVD utility continues to find strong medical support and with the pressure on healthcare systems for accurate and early disease diagnosis, the markets in which Axis-Shield operates are rapidly expanding and we are confident that the Company is well placed for future growth. We will continue to explore opportunities to acquire businesses which complement our core activities.

Since the company was taken over by Alere, it has been in a process of transition and restructuring , with the corporate activities of Axis-Shield being no longer required after de-listing on 22 November 2011. The site will soon be revised to reflect this but the company's products are still very much in demand and there has been no interruption in product quality or supply.

Axis-Shield Directors and Senior Management

thumb   John Brown PhD MBA FRSE
Non-Executive Chairman

 


Erling M H Sundrehagen   Erling M H Sundrehagen MD, MSc, PhD
Chief Scientific Officer

 

David Bond   David Bond CA
Group Financial Controller

thumb   Kjersti Grimsrud MSc, Biotechnology
Managing Director, Point-of-Care Division

Colin King   Colin King MBA
Site Director, Laboratory Division

 

thumb  

George Zajicek BPharm,
MRPharmS,

Business Development Director

© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland. - E: shield@axis-shield.com
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.